Contact
    Start Publications Bicontinuous Cubic Liquid Crystals as Potential Matrices for ...
    ←  Publication Finder
    QSense

    Bicontinuous Cubic Liquid Crystals as Potential Matrices for Non-Invasive Topical Sampling of Low-Molecular-Weight Biomarkers

    Year: 2023

    Authors: Morin, Maxim; Björklund, Sebastian; Nilsson, Emelie J.; Engblom, Johan

    Keywords: bicontinuous cubic liquid crystal; bilayer partitioning; cancer-related biomarkers; DOTAP; glycerol monooleate; humidity scanning (HS) QCM-D; kynurenine; non-invasive extraction; tryptophan; tryptophan-to-kynurenine ratio; X-ray diffraction

    Many skin disorders, including cancer, have inflammatory components. The non-invasive detection of related biomarkers could therefore be highly valuable for both diagnosis and follow up on the effect of treatment. This study targets the extraction of tryptophan (Trp) and its metabolite kynurenine (Kyn), two compounds associated with several inflammatory skin disorders. We furthermore hypothesize that lipid-based bicontinuous cubic liquid crystals could be efficient extraction matrices. They comprise a large interfacial area separating interconnected polar and apolar domains, allowing them to accommodate solutes with various properties. We concluded, using the extensively studied GMO-water system as test-platform, that the hydrophilic Kyn and Trp favored the cubic phase over water and revealed a preference for locating at the lipid–water interface. The interfacial area per unit volume of the matrix, as well as the incorporation of ionic molecules at the lipid–water interface, can be used to optimize the extraction of solutes with specific physicochemical characteristics. We also observed that the cubic phases formed at rather extreme water activities (>0.9) and that wearing them resulted in efficient hydration and increased permeability of the skin. Evidently, bicontinuous cubic liquid crystals constitute a promising and versatile platform for non-invasive extraction of biomarkers through skin, as well as for transdermal drug delivery.
    View publication